Florida Studio Theatre (FST) presents the second production of its 2019 Stage III Series: Cherry Docs by David Gow, a fearless exploration of hatred and the powerful role it plays in society. Called “Bracingly Intelligent” by The Boston Globe, Cherry Docs sheds light on the dangers of extremism and depicts how fear can quickly change into hate.
“The play takes us on a deep journey to the dark parts within all of us, where we can look at the face - the very roots of anger,” shared Kate Alexander, FST’s Associate Director At-Large and Director of Cherry Docs. “The play asks, where does hate come from? How do we face it? What is our responsibility to ourselves and to each other?”
One of the most-produced Canadian plays, Cherry Docs is a dramatic two-hander that focuses on Mike, a neo-Nazi skinhead charged with murdering an immigrant by kicking them to death, and Danny, the Jewish lawyer assigned by Legal Aid to his case. Although they have diametrically opposed belief systems, Danny and Mike are forced to work together to craft a defense for Mike. In the process, Danny is forced to examine the limits of his own liberalism and its underlying demons. This drama is an unblinking examination of hatred, the explosive eﬀect it has on our society, and the hurdles that confront us as we set about eradicating it.
FST’s production of "Cherry Docs" features Drew Hirshfield and Tom Patterson, both of whom were also part of FST’s production of Hand to God. Hirshfield has performed at numerous regional theatres across the country, including Huntington Theatre Company, Geva Theatre Center, Premiere Stages, and American Conservatory Theater. Patterson appeared in the Broadway production of 1984 and Studio Theatre’s production of Constellations, for which he won a Helen Hayes Award for Outstanding Actor in a Play.
"Cherry Docs" is a hard-hitting drama examining bigotry and redemption that runs through March 15 in FST’s Bowne’s Lab Theatre, 1241 N. Palm Ave., Sarasota. Tickets can be purchased at 941-366-9000 or floridastudiotheatre.org.